SYMPLICITY HTN-3 Renal Denervation in Patients With Uncontrolled Hypertension
Renal Denervation in Patients With Uncontrolled Hypertension (SYMPLICITY HTN-3)
Sponsor: Medtronic Vascular
Listed as NCT01418261, this NA trial focuses on Uncontrolled Hypertension and remains completed. Sponsored by Medtronic Vascular, it has been updated 10 times since 2011, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
10 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Apr 2022 — Jul 2024 [monthly]
Completed NA
-
Jan 2021 — Apr 2022 [monthly]
Completed NA
▶ Show 5 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Completed NA
-
May 2017 — Jun 2018 [monthly]
Completed NA
-
Apr 2017 — May 2017 [monthly]
Completed NA
Status: Active Not Recruiting → Completed · Phase: PHASE3 → NA
-
Feb 2017 — Apr 2017 [monthly]
Active Not Recruiting PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting PHASE3
First recorded
Sep 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Medtronic Vascular
For direct contact, visit the study record on ClinicalTrials.gov .